PerkinElmer buys London x-ray detector firm

PerkinElmer has acquired Dexela, a London-based provider of flat-panel complementary metal-oxide-semiconductor (CMOS) x-ray detection technologies and services.

The acquisition of Dexela expands PerkinElmer’s current medical imaging portfolio in areas including surgery, dental CT, cardiology and mammography, as well as non-destructive testing (NDT). With the addition of the CMOS technology to the imaging portfolio, Boston-based PerkinElmer said its customers will now be able to choose between two x-ray detector technologies to optimize their system performance and meet their specific application needs.

Founded in 2005, Dexela develops and commercializes its CMOS technology portfolio, which includes hardware and software offerings for x-ray imaging. In addition to its CMOS x-ray detection units, Dexela technologies and services include its Dexela mammography workstation, the DexView image processing software, its 3D reconstruction engine software and consulting and implementation services.

Terms of the acquisition were not disclosed.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.